Palvella Therapeutics, Inc.
125.10USD
-1.2900 (-1.02%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on PVLA.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$1.74▼ | -$1.47 | 0 | 1 |
| Next quarter | -$2.06▼ | -$1.78 | 1 | 0 |
| Current year | -$6.43▼ | -$5.57 | 0 | 1 |
| Next year | -$7.98▼ | -$6.38 | 1 | 7 |
Beat in 0 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$1.15 | -$1.52 | -0.37 (-32.0%) |
| 2026-03-31 | -$0.93 | -$1.2 | -0.27 (-29.3%) |
| 2025-12-31 | -$0.91 | -$1.08 | -0.17 (-18.6%) |
| 2025-09-30 | -$0.85 | -$1.03 | -0.18 (-21.3%) |
61 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| William Blair | Initiated | Outperform | — | Oct 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $270 $246 | Oct 12, 2026 |
| Chardan Capital | Maintained | Buy | $240 | Sep 21, 2026 |
| Stephens & Co. | Reiterated | Overweight | $220 | May 21, 2026 |
| Chardan Capital | Maintained | Buy | $240 | May 21, 2026 |
| Stephens & Co. | Initiated | Overweight | $220 | May 12, 2026 |
| Chardan Capital | Maintained | Buy | $210 $240 | Mar 31, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $255 $270 | Mar 24, 2026 |
| Chardan Capital | Maintained | Buy | $210 | Mar 16, 2026 |
| Mizuho | Maintained | Outperform | $205 $250 | Feb 25, 2026 |
| BTIG | Maintained | Buy | $192 $215 | Feb 25, 2026 |
| Chardan Capital | Maintained | Buy | $174 $210 | Feb 24, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $200 $255 | Feb 24, 2026 |
| BTIG | Reiterated | Buy | $192 | Jan 29, 2026 |
| BTIG | Reiterated | Buy | $192 | Jan 16, 2026 |
| Mizuho | Initiated | Outperform | $205 | Jan 7, 2026 |
| Truist Securities | Maintained | Buy | $105 $190 | Dec 16, 2025 |
| Canaccord Genuity | Maintained | Buy | $148 $204 | Dec 16, 2025 |
| TD Cowen | Maintained | Buy | $97 $133 | Dec 16, 2025 |
| Chardan Capital | Maintained | Buy | $110 $174 | Dec 16, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $190 $200 | Dec 15, 2025 |
| BTIG | Maintained | Buy | $167 $192 | Dec 15, 2025 |
| Clear Street | Initiated | Buy | $200 | Dec 5, 2025 |
| BTIG | Initiated | Buy | $167 | Dec 5, 2025 |
| Craig-Hallum | Initiated | Buy | $175 | Dec 4, 2025 |
69 filings from 6 insiders · 6 buy / 7 sell over 6m
Officers and directors of PVLA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Goin KathleenOfficer, Chief Operating Officer | ExerciseStock Option (Right to Buy) | 2.1k | — | — | Oct 21, 2026 |
| Goin KathleenOfficer, Chief Operating Officer | ExerciseStock Option (Right to Buy) | 2.2k | — | — | Oct 21, 2026 |
| Goin KathleenOfficer, Chief Operating Officer | Sell | 607 | $126.19 | $77k | Oct 21, 2026 |
| Goin KathleenOfficer, Chief Operating Officer | Sell | 1.7k | $125.16 | $208k | Oct 21, 2026 |
| Goin KathleenOfficer, Chief Operating Officer | Sell | 2.0k | $123.62 | $253k | Oct 21, 2026 |
| Goin KathleenOfficer, Chief Operating Officer | Exercise | 2.1k | $9.08 | $20k | Oct 21, 2026 |
| Goin KathleenOfficer, Chief Operating Officer | Exercise | 2.2k | $7.14 | $15k | Oct 21, 2026 |
| JENKINS GEORGE MDirector | Sell | 505 | $126.55 | $64k | Oct 14, 2026 |
| JENKINS GEORGE MDirector | Sell | 597 | $125.33 | $75k | Oct 14, 2026 |
| JENKINS GEORGE MDirector | Sell | 920 | $124.37 | $114k | Oct 14, 2026 |
| JENKINS GEORGE MDirector | Sell | 2.6k | $123.29 | $321k | Oct 14, 2026 |
| JENKINS GEORGE MDirector | Sell | 2.1k | $122.62 | $254k | Oct 14, 2026 |
| JENKINS GEORGE MDirector | Sell | 476 | $121.14 | $58k | Oct 14, 2026 |
| JENKINS GEORGE MDirector | Sell | 922 | $133.72 | $123k | Oct 13, 2026 |
| JENKINS GEORGE MDirector | Sell | 579 | $132.40 | $77k | Oct 13, 2026 |
| JENKINS GEORGE MDirector | Sell | 1.0k | $131.49 | $136k | Oct 13, 2026 |
| JENKINS GEORGE MDirector | Sell | 990 | $130.48 | $129k | Oct 13, 2026 |
| JENKINS GEORGE MDirector | Sell | 1.6k | $129.23 | $212k | Oct 13, 2026 |
| JENKINS GEORGE MDirector | Sell | 2.0k | $128.52 | $258k | Oct 13, 2026 |
| JENKINS GEORGE MDirector | Sell | 817 | $136.44 | $111k | Oct 12, 2026 |
No analyst notes on PVLA yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 16 | 0 | 0 | 0 | Buy2.00 |
| 1 mo ago | 0 | 15 | 0 | 0 | 0 | Buy2.00 |
| 2 mo ago | 0 | 15 | 0 | 0 | 0 | Buy2.00 |
| 3 mo ago | 0 | 15 | 0 | 0 | 0 | Buy2.00 |
Members whose judged calls on PVLA have played out most reliably.
No settled calls on PVLA yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice